ATHE · ALTERITY THERAPEUTICS LTD

NasdaqHealthcareBiotechnology

Alterity Therapeutics Ltd

HealthcareNasdaqAU

$6.78

+57.2% latest move

Price & move as of the most recent catalyst (Jun 9) — not a live quote.

FLOAT

92.0M

FREE FLOAT %

42%

SHARES O/S

217.5M

MARKET CAP

$54.4M

EXCHANGE

Nasdaq

COUNTRY

ATHE Catalyst History

FDA agrees to Phase 3 design including UMSARS Part I as primary endpoint.

Be early on the next ATHE spark.

Day Trader Sniper alerts you the instant a setup like this triggers.